Citation: | LU Fei, ZHANG Ning, KANG Lin, SUN Xiaohong, TIAN Ran, GUO Xiaoxiao, LIU Yongjian, ZHANG Wen, PENG Linyi, SU Tong, CAO Jian, WANG Yining, QIAN Min, CAO Yuze, YANG Lu, LIU Yuehua, ZHANG Lu, ZHAO Xiaoyi, LENG Ling. Decreased Muscle Strength, Type 2 Respiratory Failure, Heart Failure, Positive Anti-mitochondrial Antibodies—Rare Atypical Manifestations of Inflammatory Myopathy[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(1): 138-146. DOI: 10.12290/xhyxzz.2020-0109 |
[1] |
Choudhury S, Ramos M, Anjum H, et al. Shrinking Lung Syndrome: A Rare Manifestation of Systemic Lupus Erythematosus[J]. Cureus, 2020, 12: e8216.
|
[2] |
Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts)[J]. N Engl J Med, 1975, 292: 344-347. DOI: 10.1056/NEJM197502132920706
|
[3] |
Lundberg IE, Tjärnlund A, Bottai M, et al. 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and their Major Subgroups[J]. Arthritis Rheumatol, 2017, 69: 2271-2282. DOI: 10.1002/art.40320
|
[4] |
European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of cholestatic liver diseases[J]. J Hepatol, 2009, 51: 237-267. DOI: 10.1016/j.jhep.2009.04.009
|
[5] |
Albayda J, Khan A, Casciola-Rosen L, et al. Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement[J]. Semin Arthritis Rheum, 2018, 47: 552-556. DOI: 10.1016/j.semarthrit.2017.06.004
|
[6] |
Huang Y, Liu H, Wu C, et al. Ventricular arrhythmia predicts poor outcome in polymyositis/dermatomyositis with myocardial involvement[J]. Rheumatology (Oxford), 2021, 60: 3809-3816. DOI: 10.1093/rheumatology/keaa872
|
[7] |
Lo JA, Fisher DE. The melanoma revolution: from UV carcinogenesis to a new era in therapeutics[J]. Science, 2014, 346: 945-949. DOI: 10.1126/science.1253735
|
[8] |
Dalakas MC. Inflammatory muscle diseases[J]. N Engl J Med, 2015, 372: 1734-47. DOI: 10.1056/NEJMra1402225
|
[9] |
Selva-O'Callaghan A, Pinal-Fernandez I, Trallero-Araguás E, et al. Classification and management of adult inflam-matory myopathies[J]. Lancet Neurol, 2018, 17: 816-828. DOI: 10.1016/S1474-4422(18)30254-0
|
[10] |
薄传强. 特发性炎性肌病[J]. 中华神经科杂志, 2019, 52: 410-422. DOI: 10.3760/cma.j.issn.1006-7876.2019.05.009
Bu CQ. Idiopathic inflammatory myopathy[J]. Zhonghua Shenjingke Zazhi, 2019, 52: 410-421. DOI: 10.3760/cma.j.issn.1006-7876.2019.05.009
|
[11] |
Hou Y, Liu M, Luo YB, et al. Idiopathic inflammatory myopathies with anti-mitochondrial antibodies: Clinical features and treatment outcomes in a Chinese cohort[J]. Neuromuscul Disord, 2019, 29: 5-13. DOI: 10.1016/j.nmd.2018.11.004
|
[12] |
Mauhin W, Mariampillai K, Allenbach Y, et al. Anti-mitochondrial antibodies are not a hallmark of severity in idiopathic inflammatory myopathies[J]. Joint Bone Spine, 2018, 85: 375-376. DOI: 10.1016/j.jbspin.2017.04.004
|
[13] |
Maeda MH, Tsuji S, Shimizu J. Inflammatory myopathies associated with anti- mitochondrial antibodies[J]. Brain, 2012, 135: 1767-1777. DOI: 10.1093/brain/aws106
|
[14] |
Uenaka T, Kowa H, Ohtsuka Y, et al. Less limb muscle involvement in myositis patients with anti-mitochondrial antibodies[J]. Eur Neurol, 2017, 78: 290-295. DOI: 10.1159/000481503
|
[1] | ZHANG Shan, LIU Jie. Interpretation of NCCN Clinical Practice Guidelines for Primary Cutaneous Lymphomas (Version 1.2024) Based on the Current Diagnosis and Treatment Status of China[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(5): 1029-1037. DOI: 10.12290/xhyxzz.2024-0605 |
[2] | LUO Fuchao, ZHANG Junhua, CHENG Peng, WU Jing, ZHONG Bin, LYU Bing, HUANG Guogang, LIU Yang, ZHANG Zexue, WEI Xiaohong. Clinical Application of Ultrasound-guided RISS Plane Block for Postoperative Analgesia After Minimally Invasive McKeown Esophagectomy: A Prospective Randomized Controlled Study[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(3): 624-631. DOI: 10.12290/xhyxzz.2023-0358 |
[3] | ZHU He, WEN Bei, XU Li, HUANG Yuguang. Mechanism of Wnt5a on Keratinocyte Regulating MMP9 for CRPS-Ⅰ Peripheral Sensitization[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(2): 335-343. DOI: 10.12290/xhyxzz.2023-0551 |
[4] | ZHANG Lu, LI Jian. Castleman Disease in China: State-of-the-art Technology Before the Era of IL-6 Targeted Therapy[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 911-914. DOI: 10.12290/xhyxzz.2023-0227 |
[5] | LIU Yuan, ZHAO Lin. Update and Interpretation of 2022 National Comprehensive Cancer Network Clinical Practice Guidelines for Gastric Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 999-1004. DOI: 10.12290/xhyxzz.2022-0271 |
[6] | ZHANG Shan, LIU Zhaorui, LIU Jie. Relationship Between SerpinB9 and Tumors and Research Progress of SerpinB9 in Skin Tumors[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(5): 852-857. DOI: 10.12290/xhyxzz.2021-0805 |
[7] | Qi JIN, Qin LUO, Zhi-hui ZHAO, Zhi-hong LIU. MicroRNA-21 in the Pathogenesis of Pulmonary Hypertension[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(4): 430-438. DOI: 10.3969/j.issn.1674-9081.2020.04.013 |
[8] | Hao GUO, Wen-da WANG, Yi CAI, Yu-shi ZHANG. Progress in Research on MicroRNA in Tuberous Sclerosis Complex Related Diseases[J]. Medical Journal of Peking Union Medical College Hospital, 2017, 8(4-5): 283-288. DOI: 10.3969/j.issn.1674-9081.2017.05.017 |